Effects of Spirulina supplementation on ulcerative colitis patients

Not Applicable

• Conditions: lcerative colitis patients.; Ulcerative colitis, unspecified; K51.9

• Registration Number: IRCT20191204045612N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with mild to moderate ulcerative colitis in the age range of 18 to 65 years

Exclusion Criteria

Patients with severe ulcerative colitis
Individuals in pregnancy or breastfeeding condition.
Taking antidepressants and anxiety medications.
Taking antioxidant and omega-3 supplements in the last three months.
Smokers or alcohol consumers.
Patients with kidney, liver, thyroid and parathyroid, gastrointestinal and heart disease and cancer disease.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pentraxin 3. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: Eliza kit.;Total antioxidant capacity. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: Diagnostic kit.;Malondialdehyde. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: Diagnostic kit.;Superoxide dismutase. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: Diagnostic kit.;Erythrocyte Sedimentation Rate. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: Measurement of erythrocyte sedimentation rate.;Disease activity indices. Timepoint: Before intervention and 8 weeks after initiation of Spirulina supplementation. Method of measurement: SCCAI questionnaire.